-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Mirum Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q2 2024.
- Mirum Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$24.2M, a 0.17% increase year-over-year.
- Mirum Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$108M, a 8.47% increase year-over-year.
- Mirum Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$109M, a 16.8% increase from 2022.
- Mirum Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$131M, a 24.3% increase from 2021.
- Mirum Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$173M, a 66.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)